Skip to content
★ Sign in to follow
SL

Stina Lundgren

Medivir AB
Total declarations
2
Company
1
▲ Purchases (1 ops.)
—
▼ Sales (1 ops.)
€1,753

Latest filing published 20 Feb 2017 for Medivir AB, €1,753.

Filing timeline

BuySale
Stina Lundgren

Insider track record

Disclosed buys
1
Disclosed sells
1
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Stina Lundgren: trading record in brief

Stina Lundgren is a declared insider of Medivir AB, with filings sourced from Finansinspektionen. The record holds 2 filings, for trades running from 13 January 2017 to 20 February 2017.

Both buying and selling appear: 1 purchase, against 1 sale worth €1,753. The totals do not cover 1 filing with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

The newest entry dates from 20 February 2017: an open-market sale of €1,753, in Medivir AB. The most recent open-market purchase was published on 21 January 2017, 3,579 days ago. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.

Companies and markets linked to Stina Lundgren

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▼
    Styrelseledamot/suppleantExecutivesMedivir AB
    16,591 SEK33FI-SE
    1,338 shares@ SEK 12.40100.0% of flowISIN SE0009580426FI:csv-073a454d28de5a686724
  • ▲
    Styrelseledamot/suppleantExecutivesMedivir AB
    0FI-SE
    129 shares0ISIN SE0000273294FI:csv-87426be48782cc53c994
    Canonical exit: 13 Apr 2017 (T+90)

2 of 2 declarations